Niki BioSolutions
NIKI9.6109.58% ( +0.840 )
Niki BioSolutions (NIKI)
Niki BioSolutions, Inc., through its subsidiaries, operates as a clinical-stage biopharmaceutical company and engages in the discovery, development, and commerc...
- Open
- 8.590
- High
- 9.760
- Low
- 8.450
- Prev. Close
- 8.770
- Volume
- 28.27K
- Turnover
- 257.81K
- Avg Price
- 9.121
- Bid/Ask Ratio
- --
- Amplitude
- 14.94%
- 52wk High
- 12.240
- Volume Ratio
- 0.05
- Turnover Ratio
- 5.27%
Niki BioSolutions Analyst Rating
View MoreForecast & Rating
May 6, 2023Price forecast
$1500.0015508.74%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- TradingView · Jul 24 at 03:36 PM
Kira Sheinerman Secures Board Rights at Niki BioSolutions with 51.56% Stake
- US Stock Market Update · Jul 23 at 02:10 PM
Niki BioSolutions falls 9% as gains fade after gene testing deal
- US Stock Market Update · Jul 23 at 12:32 PM
Niki BioSolutions falls 5% as early 44% surge fades
- US Stock Market Update · Jul 23 at 09:00 AM
Niki BioSolutions climbs 2% on APOE testing deal after 44% premarket surge
- benzinga_article · Jul 23 at 07:06 AM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- benzinga_article · Jul 23 at 07:04 AM
Niki BioSolutions shares are trading higher after the company announced its subsidiary, DiamiR Biosciences, entered into agreement to provide Progressive Medical Research with Apolipoprotein E genotyping services.
